---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-21-003475"
form_type: "8-K"
ticker: "CMMB"
cik: "0001534248"
company_name: "Chemomab Therapeutics Ltd."
filed_at: "2021-11-10T23:59:59+00:00"
generated_at: "2026-06-28T09:53:21.824913+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "medium"
source: SEC EDGAR
---

# Chemomab Therapeutics files updated corporate presentation on November 10, 2021

## Summary
- Filed Form 8-K on Nov 10, 2021, including Items 7.01 (Regulation FD) and 9.01 (Exhibits).
- Attached updated corporate presentation as Exhibit 99.1, highlighting treatments for fibrotic diseases.
- Company based in Kiryat Atidim, Tel Aviv, with ADS trading on Nasdaq under ticker CMMB.

## SEC filing metadata
- accession: 0001178913-21-003475
- form_type: 8-K
- ticker: CMMB
- cik: 0001534248
- company_name: Chemomab Therapeutics Ltd.
- filed_at: 2021-11-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534248/000117891321003475/0001178913-21-003475-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534248/000117891321003475/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-21-003475
- JSON: https://secwatch.observer/filing/0001178913-21-003475.json
- Plain text: https://secwatch.observer/filing/0001178913-21-003475.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.